the history of SNB in the management of melanoma
its current role in the stratification of patients into those who may benefit from adjuvant therapies verses those for whom active surveillance is more appropriate
other potential benefits of SNB, including the likelihood of SNB itself reducing the risk of nodal recurrence.
This podcast is suitable for Surgeons, Medical Oncologists, General Practitioners and other healthcare professionals.
SPEAKERS
A/Prof Sydney Ch’ng - Plastic & Reconstructive Surgeon and Head & Neck Surgeon, Melanoma Institute Australia | Associate Professor of Surgery, The University of Sydney
Prof Georgina Long AO - Co-Medical Director, Melanoma Institute Australia | Chair, Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia and Royal North Shore Hospital, The University of Sydney
Prof John Thompson AO - Emeritus Professor of Melanoma and Surgical Oncology, The University of Sydney | Senior Surgeon, Melanoma Institute Australia
Please note that this podcast was accurate at the time of recording (July 2022) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.
Podden och tillhörande omslagsbild på den här sidan tillhör
Melanoma Institute Australia. Innehållet i podden är skapat av Melanoma Institute Australia och inte av,
eller tillsammans med, Poddtoppen.